Synovus Financial Corp Blueprint Medicines Corp Transaction History

Synovus Financial Corp

$7.79 Billion
Q4 2024

A detailed history of Synovus Financial Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Synovus Financial Corp holds 24,528 shares of BPMC stock, worth $2.21 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,528

Previous 24,047 2.0%

Holding current value

$2.21 Million

Previous $2.22 Million 3.78%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$82.48 - $101.39 $39,672 - $48,768	481 Added 2.0%	24,528 $2.14 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $77,540 - $111,101	922 Added 3.99%	24,047 $2.22 Million
Q2 2024 Aug 13, 2024	SELL	$85.18 - $108.78 $664,063 - $848,048	-7,796 Reduced 25.21%	23,125 $2.49 Million
Q1 2024 May 14, 2024	SELL	$73.17 - $99.79 $678,798 - $925,751	-9,277 Reduced 23.08%	30,921 $2.93 Million
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $13,272 - $18,678	-283 Reduced 0.7%	40,198 $2.02 Million
Q2 2023 Aug 08, 2023	SELL	$42.2 - $66.37 $111,070 - $174,685	-2,632 Reduced 6.1%	40,481 $2.56 Million
Q1 2023 May 11, 2023	SELL	$37.97 - $50.0 $178,838 - $235,500	-4,710 Reduced 9.85%	43,113 $1.94 Million
Q4 2022 Feb 06, 2023	BUY	$41.06 - $66.48 $552,913 - $895,219	13,466 Added 39.19%	47,823 $2.1 Million
Q3 2022 Oct 27, 2022	BUY	$49.93 - $77.7 $240,063 - $373,581	4,808 Added 16.27%	34,357 $2.26 Million
Q2 2022 Aug 10, 2022	BUY	$45.23 - $70.15 $127,819 - $198,243	2,826 Added 10.58%	29,549 $1.49 Million
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $287,703 - $585,405	5,318 Added 24.84%	26,723 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $20,640 - $25,401	219 Added 1.03%	21,405 $2.29 Million
Q3 2021 Nov 08, 2021	BUY	$80.98 - $109.47 $491,872 - $664,920	6,074 Added 40.19%	21,186 $2.17 Million
Q2 2021 Aug 11, 2021	BUY	$82.78 - $101.0 $65,396 - $79,790	790 Added 5.52%	15,112 $1.33 Million
Q1 2021 May 11, 2021	BUY	$90.71 - $108.28 $1.3 Million - $1.55 Million	14,322 New	14,322 $1.39 Million
Q3 2020 Nov 09, 2020	SELL	$66.45 - $92.7 $4,186 - $5,840	-63 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$58.91 - $78.32 $3,711 - $4,934	63 New	63 $5,000

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.37B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Blueprint Medicines Corp Transaction History